28088318|t|Correlation of the HPV detection, protein expression and DNA content in cutaneous pre-invasive and invasive carcinoma among Croatian patients
28088318|a|Development of cutaneous carcinomas has been associated with HPV infection. There have been various reports on p16, p53 and pRb expression in cutaneous carcinomas and on its linkage to HPV status. Association of protein expression and HPV infection with DNA content is not clear. The aim of this study was to determine a possible correlation between HPV type, protein expression and DNA content in both pre-invasive and invasive squamous cell carcinoma, as well as differences between studied groups in these parameters. Sections of formalin fixed paraffin-embedded tumor tissue from 54 cases of Morbus Bowen (preinvasive cutaneous carcinoma) and 41 cases of invasive squamous cell carcinoma of the skin were subjected to HPV genotyping using Lipa (Line imuno probe assay), immunohistochemical staining for p16(INK4A), p53, pRb and prepared for flow cytometry DNA content analysis. Obtained data were analyzed in SPSS using Chi square test. Only p16 expression showed statistically significant differences in studied groups. Statistically significant correlations were found only in MB between parameters HPV - p53, p53 - pRb and p53 - p16. Our results suggest different virus - induced pathobiology pathways for different cutaneous carcinoma groups.
28088318	0	11	Correlation	T080	C1707520
28088318	19	32	HPV detection	T059	C0201678
28088318	34	52	protein expression	T045	C1171362
28088318	57	68	DNA content	T081	C0032246
28088318	72	81	cutaneous	T082	C0221912
28088318	82	94	pre-invasive	T191	C0007099
28088318	99	117	invasive carcinoma	T191	C1334274
28088318	124	132	Croatian	T098	C1257890
28088318	133	141	patients	T101	C0030705
28088318	157	177	cutaneous carcinomas	T191	C0154073
28088318	187	202	associated with	T080	C0332281
28088318	203	216	HPV infection	T047	C0343641
28088318	242	249	reports	T170	C0684224
28088318	253	256	p16	T116,T123	C0249880
28088318	258	261	p53	T116,T123	C0080055
28088318	266	269	pRb	T116,T123	C0080113
28088318	270	280	expression	T045	C1171362
28088318	284	304	cutaneous carcinomas	T191	C0154073
28088318	316	323	linkage	T044	C0023745
28088318	327	330	HPV	T005	C0021344
28088318	354	372	protein expression	T045	C1171362
28088318	377	390	HPV infection	T047	C0343641
28088318	396	407	DNA content	T081	C0032246
28088318	472	483	correlation	T080	C1707520
28088318	492	495	HPV	T005	C0021344
28088318	502	520	protein expression	T045	C1171362
28088318	525	536	DNA content	T081	C0032246
28088318	545	557	pre-invasive	T191	C0007099
28088318	562	570	invasive	T080	C0205281
28088318	571	594	squamous cell carcinoma	T191	C0007137
28088318	635	641	groups	T098	C1257890
28088318	651	661	parameters	T033	C0449381
28088318	663	671	Sections	T167	C1522472
28088318	675	720	formalin fixed paraffin-embedded tumor tissue	T024	C2711483
28088318	729	734	cases	T077	C1706256
28088318	738	750	Morbus Bowen	T191	C0006079
28088318	752	783	preinvasive cutaneous carcinoma	T191	C0154073
28088318	792	797	cases	T077	C1706256
28088318	801	809	invasive	T080	C0205281
28088318	810	833	squamous cell carcinoma	T191	C0007137
28088318	841	845	skin	T022	C1123023
28088318	864	878	HPV genotyping	T059	C2368152
28088318	885	889	Lipa	T059	C3539666
28088318	891	913	Line imuno probe assay	T059	C3539666
28088318	916	935	immunohistochemical	T059	C1441616
28088318	936	944	staining	T059	C0487602
28088318	949	959	p16(INK4A)	T116,T123	C0249880
28088318	961	964	p53	T116,T123	C0080055
28088318	966	969	pRb	T116,T123	C0080113
28088318	974	982	prepared	T033	C4082130
28088318	987	1022	flow cytometry DNA content analysis	T059	C0200905
28088318	1066	1081	Chi square test	T170	C0008041
28088318	1088	1102	p16 expression	T045	C1171362
28088318	1110	1135	statistically significant	T081	C0237881
28088318	1136	1147	differences	T080	C1705242
28088318	1167	1192	Statistically significant	T081	C0237881
28088318	1193	1205	correlations	T080	C1707520
28088318	1236	1246	parameters	T033	C0449381
28088318	1247	1250	HPV	T005	C0021344
28088318	1253	1256	p53	T116,T123	C0080055
28088318	1258	1261	p53	T116,T123	C0080055
28088318	1264	1267	pRb	T116,T123	C0080113
28088318	1272	1275	p53	T116,T123	C0080055
28088318	1278	1281	p16	T116,T123	C0249880
28088318	1313	1318	virus	T005	C0042776
28088318	1321	1328	induced	T169	C0205263
28088318	1329	1350	pathobiology pathways	T077	C1511986
28088318	1365	1384	cutaneous carcinoma	T191	C0154073
28088318	1385	1391	groups	T098	C1257890